The future of psychedelic medicines and healthcare | Shoshana Clubhouse Conversation

episode

TED Health not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

The Art of True Happiness | Dr. Arthur Brooks 2h 49m · 14 Sep 2026 · Huberman Lab

The Chris Wolfe Podcast: The Power of Quality Supplements 48 min · 14 Sep 2026 · EyeCode Media

1208: TM Europe win the '26 Solheim Cup 1h 49m · 13 Sep 2026 · No Laying Up - Golf Podcast

MORNING TEA: Harry & Meghan's Brutal SNL Roast, Lady Gaga's Baby News & Dakota Johnson's New Man 8 min · 13 Sep 2026 · The Spill

"I don't think they have enough match winners."| First Thoughts - Brisbane vs Adelaide (14.09.26) 15 min · 13 Sep 2026 · SEN Breakfast

Full Show Podcast: 14 September 2026 1h 28m · 13 Sep 2026 · The Mike Hosking Breakfast

Report any issue

Source

Recorded09 Nov 2021

Publisherfeeds.acast.com ↗

Handlerec:4255192

Show notes

We’re in the midst of a psychedelic renaissance, where this once demonized class of drugs is now front and center receiving attention among entrepreneurs, investors, clinical trials and even patients. In this special conversation, TED Health’s Dr. Shoshana Ungerleider speaks with 3 psychedelic medical experts: internist Dr. Molly Maloof, psychiatrist and neuroscientist Dr. Dave Rabin and palliative care and oncologist Dr. Anthony Back, about how these compounds may revolutionize the future of mental healthcare. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in